A 59-year-old female patient with advanced lung adenocarcinoma developed acute left heart failure after one cycle of immunotherapy with tislelizumab 200 mg.The brain natriuretic peptide was significantly increased,and the myocardial enzyme spectrum remained normal.The cause may be immune-related non-myocardial inflammatory left ventricular dysfunction.After active glucocorticoid therapy,the patient's symptoms of heart failure were significantly relieved,but left ventricular dysfunction could not be reversed.Therefore,for patients with tumor immunotherapy of left ventricular function after injury,while myocardial enzyme spectrum continue to normal,still should take into account the immune correlation of the left ventricular function of myocardial inflammatory damage,need to use hormone therapy,and the left ventricular function damage is irreversible.
关键词
替雷利珠单抗/非心肌炎性的左心室功能损害/免疫相关不良事件
Key words
Tirelizumab/Left ventricular dysfunction without myocardial inflammation/Immune-related adverse events
维普
万方数据